Socioeconomic Inequalities of Long COVID: a Retrospective Population-based Cohort Study in the United Kingdom

Overview

Journal J R Soc Med

Specialty General Medicine

Date 2023 May 10

PMID 37164035

Authors

Sharmin Shabnam

Cameron Razieh

Hajira Dambha-Miller

Tom Yates

Clare Gillies

Yogini V Chudasama

Manish Pareek

Amitava Banerjee

Ichiro Kawachi

Ben Lacey

Eva Ja Morris

Martin White

Francesco Zaccardi

Kamlesh Khunti

Nazrul Islam

Affiliations

Soon will be listed here.

Abstract

Objectives: To estimate the risk of Long COVID by socioeconomic deprivation and to further examine the inequality by sex and occupation.

Design: We conducted a retrospective population-based cohort study using data from the ONS COVID-19 Infection Survey between 26 April 2020 and 31 January 2022. This is the largest nationally representative survey of COVID-19 in the UK with longitudinal data on occupation, COVID-19 exposure and Long COVID.

Setting: Community-based survey in the UK.

Participants: A total of 201,799 participants aged 16 to 64 years and with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Main Outcome Measures: The risk of Long COVID at least 4 weeks after SARS-CoV-2 infection by index of multiple deprivation (IMD) and the modifying effects of socioeconomic deprivation by sex and occupation.

Results: Nearly 10% ( = 19,315) of participants reported having Long COVID. Multivariable logistic regression models, adjusted for a range of variables (demographic, co-morbidity and time), showed that participants in the most deprived decile had a higher risk of Long COVID (11.4% vs. 8.2%; adjusted odds ratio (aOR): 1.46; 95% confidence interval (CI): 1.34, 1.59) compared to the least deprived decile. Significantly higher inequalities (most vs. least deprived decile) in Long COVID existed in healthcare and patient-facing roles (aOR: 1.76; 95% CI: 1.27, 2.44), in the education sector (aOR: 1.68; 95% CI: 1.31, 2.16) and in women (aOR: 1.56; 95% CI: 1.40, 1.73) than men (aOR: 1.32; 95% CI: 1.15, 1.51).

Conclusions: This study provides insights into the heterogeneous degree of inequality in Long COVID by deprivation, sex and occupation. These findings will help inform public health policies and interventions in incorporating a social justice and health inequality lens.

Citing Articles

The ongoing importance of patient-informed, collaborative research in advancing the definition and harmonization of post COVID-19 condition (PCC) subtypes across diverse populations.

Collins E, Shaver N, Little J EBioMedicine. 2025; 113:105592.

PMID: 39923741 PMC: 11850169. DOI: 10.1016/j.ebiom.2025.105592.

Understanding long COVID: prevalence, characteristics, and risk factors in the Eastern Province of Saudi Arabia.

Aldhawyan A, A BuSaad M, Almaghlouth N, Alnasser A, Alnasser J, Almansour A Front Med (Lausanne). 2024; 11:1459583.

PMID: 39430594 PMC: 11486694. DOI: 10.3389/fmed.2024.1459583.

Prevalence of COVID-19 and Long COVID by Industry and Occupation: Behavioral Risk Factor Surveillance System 2022.

Silver S, Li J, Ford N, Shi D, Saydah S Am J Ind Med. 2024; 68(1):26-52.

PMID: 39392098 PMC: 11649465. DOI: 10.1002/ajim.23665.

Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study.

Greenwood D, Mansoubi M, Bakerly N, Bhatia A, Collett J, Davies H Lancet Reg Health Eur. 2024; 46:101082.

PMID: 39381546 PMC: 11458954. DOI: 10.1016/j.lanepe.2024.101082.

Non-pharmaceutical interventions: evaluating challenges and priorities for future health shocks.

Majeed A, Quint J, Bhatt S, Davies F, Islam N BMJ. 2024; 387:e080528.

PMID: 39374974 PMC: 11450877. DOI: 10.1136/bmj-2024-080528.

References

Sudre C, Murray B, Varsavsky T, Graham M, Penfold R, Bowyer R . Attributes and predictors of long COVID. Nat Med. 2021; 27(4):626-631. PMC: 7611399. DOI: 10.1038/s41591-021-01292-y. View

Ramos-Casals M, Brito-Zeron P, Mariette X . Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol. 2021; 17(6):315-332. PMC: 8072739. DOI: 10.1038/s41584-021-00608-z. View

. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records using OpenSAFELY. Br J Gen Pract. 2021; 71(712):495. PMC: 8544137. DOI: 10.3399/bjgp21X717449. View

Kamal M, Abo Omirah M, Hussein A, Saeed H . Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2020; 75(3):e13746. PMC: 7536922. DOI: 10.1111/ijcp.13746. View

Nguyen L, Drew D, Graham M, Joshi A, Guo C, Ma W . Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020; 5(9):e475-e483. PMC: 7491202. DOI: 10.1016/S2468-2667(20)30164-X. View

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Kapilashrami A, Hankivsky O . Intersectionality and why it matters to global health. Lancet. 2018; 391(10140):2589-2591. DOI: 10.1016/S0140-6736(18)31431-4. View

Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G . Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022; 13(1):1957. PMC: 9005552. DOI: 10.1038/s41467-022-29521-z. View

Gillies C, Rowlands A, Razieh C, Nafilyan V, Chudasama Y, Islam N . Association between household size and COVID-19: A UK Biobank observational study. J R Soc Med. 2022; 115(4):138-144. PMC: 8972956. DOI: 10.1177/01410768211073923. View

10.

Mutambudzi M, Niedwiedz C, Macdonald E, Leyland A, Mair F, Anderson J . Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants. Occup Environ Med. 2020; . PMC: 7611715. DOI: 10.1136/oemed-2020-106731. View

11.

Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2021; 28(4):611.e9-611.e16. PMC: 8575536. DOI: 10.1016/j.cmi.2021.11.002. View

12.

Venkatesan P . NICE guideline on long COVID. Lancet Respir Med. 2021; 9(2):129. PMC: 7832375. DOI: 10.1016/S2213-2600(21)00031-X. View

13.

Miller I, Becker A, Grenfell B, Metcalf C . Disease and healthcare burden of COVID-19 in the United States. Nat Med. 2020; 26(8):1212-1217. DOI: 10.1038/s41591-020-0952-y. View

14.

Ayoubkhani D, Bermingham C, Pouwels K, Glickman M, Nafilyan V, Zaccardi F . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022; 377:e069676. PMC: 9115603. DOI: 10.1136/bmj-2021-069676. View

15.

Thompson E, Williams D, Walker A, Mitchell R, Niedzwiedz C, Yang T . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022; 13(1):3528. PMC: 9240035. DOI: 10.1038/s41467-022-30836-0. View

16.

Ziauddeen N, Gurdasani D, OHara M, Hastie C, Roderick P, Yao G . Characteristics and impact of Long Covid: Findings from an online survey. PLoS One. 2022; 17(3):e0264331. PMC: 8903286. DOI: 10.1371/journal.pone.0264331. View

17.

Islam N, Shkolnikov V, Acosta R, Klimkin I, Kawachi I, Irizarry R . Excess deaths associated with covid-19 pandemic in 2020: age and sex disaggregated time series analysis in 29 high income countries. BMJ. 2021; 373:n1137. PMC: 8132017. DOI: 10.1136/bmj.n1137. View

18.

Kontopantelis E, Mamas M, Webb R, Castro A, Rutter M, Gale C . Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study. PLoS Med. 2022; 19(2):e1003904. PMC: 8846534. DOI: 10.1371/journal.pmed.1003904. View

19.

Razieh C, Zaccardi F, Islam N, Gillies C, Chudasama Y, Rowlands A . Ethnic minorities and COVID-19: examining whether excess risk is mediated through deprivation. Eur J Public Health. 2021; 31(3):630-634. PMC: 8083789. DOI: 10.1093/eurpub/ckab041. View

20.

Desai A, Lavelle M, Boursiquot B, Wan E . Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2021; 322(1):C1-C11. PMC: 8721906. DOI: 10.1152/ajpcell.00375.2021. View